GGrantIndex
Sort

21,281 grants matching influenza

Eosinophils, Inflammation and Immunity

$723,373
Helene Rosenberg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

Community-based Design and Evaluation of a Conversational Agent to Promote SARS-COV2 Vaccination in Black Churches

$723,305
Timothy W Bickmore · Northeastern University · R01 · FY2022 · MD

Combination nanovaccine-based immunization against influenza virus in the aged: immunity and protection

$723,073
Marian L Kohut · Iowa State University · R01 · FY2022 · AI

Case-Cohort Study of Cancers in Excess in Poultry Workers

$723,016
Eric S. Johnson · Univ Of Arkansas For Med Scis · R01 · FY2012 · OH

Developing a Paramyxovirus-based H5N1 Vaccine

$722,969
Biao He · University Of Georgia · R01 · FY2012 · AI

Monocyte-derived galectin-1 promotes tissue-resident memory T cell response

$722,958
Minsoo Kim · University Of Rochester · R01 · FY2025 · AI

Engineering protease-resistant antiviral peptide inhibitors for SARS-CoV-2

$722,958
Anne Moscona · Columbia University Health Sciences · R01 · FY2022 · AI

Pre-Existing Atopy and Respiratory Viral Infections

$722,806
Mitchell H Grayson · Research Inst Nationwide Children'S Hosp · R01 · FY2023 · AI

Clinical Diagnostic Studies and Treatment of Patients with Immune Deficiencies

$722,652
Suk De Ravin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Meditation and Exercise for Preventing Acute Respiratory Infection (MEPARI-2)

$722,614
Bruce P Barrett · University Of Wisconsin-Madison · R01 · FY2015 · AT

Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination

$722,300
Frances E. Lund · University Of Alabama At Birmingham · R01 · FY2020 · AI

Development of a novel quadrivalent seasonal influenza vaccine using E.coli production technology

$722,269
Shengqiang Li · Sciogen, Llc · R44 · FY2017 · AI

Development of lung T cell responses in infant respiratory immunity

$722,112
Donna L Farber · Columbia University Health Sciences · R01 · FY2015 · AI

Biophysical studies of macromolecules and molecular assemblies

$722,065
Steven G. Boxer · Stanford University · R35 · FY2021 · GM

Impact of repeated vaccination on the effectiveness of seasonal influenza vaccines

$722,061
Xiufeng Henry Wan · University Of Missouri-Columbia · R01 · FY2024 · AI

Development of an RSV vaccine for the elderly

$721,972
Trudy G. Morrison · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · AI

Development of an RSV vaccine for the elderly

$721,972
Trudy G. Morrison · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · AI

Development of an RSV vaccine for the elderly

$721,972
Trudy G. Morrison · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · AI

Development of an RSV vaccine for the elderly

$721,972
Trudy G. Morrison · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · AI

Factors influencing TRM responses in upper airway tissue

$721,915
Pandurangan Vijayanand · La Jolla Institute For Immunology · U19 · FY2024 · AI

Syrian hamsters as an animal model for influenza virus research

$721,773
Yoshihiro Kawaoka · University Of Wisconsin-Madison · R01 · FY2020 · AI

Control of influenza virus induced type I interferon signaling during pregnancy

$721,696
Nicholas S Heaton · Duke University · R01 · FY2024 · AI

Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex

$721,646
Delisa Fairweather · Mayo Clinic Jacksonville · R01 · FY2025 · HL

Combined adjuvant approaches for enhancement of SARS-CoV-2 vaccine efficacy

$721,321
Pamela Tinmoi Wong · University Of Michigan At Ann Arbor · R01 · FY2025 · AI

Inhaled Large Porous Particles for Treatment of MDR-TB

$721,165
Harvard University · U01 · FY2005 · AI